Abstract:Guoming Zeng, 1, 2, * Libo Jin, 3, 4, * Qinsi Ying, 5 Haojie Chen, 3 Murinda Charmaine Thembinkosi, 3 Chunguang Yang, 6 Jinlong Zhao, 6 Hao Ji, 3 Sue Lin, 3 Renyi Peng, 3 Maolan Zhang, 1, 3 Da Sun 3 1 Chongqing University of Science and Technology, Chongqing 401331, People's Republic of China; 2 China Metallurgical Construction Engineering Group Co., Ltd., Chongqing 400044, People's Republic of China; 3 Institute of Life Sciences, Wenzhou University, Wenzhou, Zhejiang 325035, People's Republic of China; 4 Biomedical Collaborative Innovation Center of Zhejiang Province & Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou, Zhejiang 325035, People's Republic of China; 5 Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325035, People's Republic of China; 6 Institute of Metal Research, Chinese Academy of Sciences, Shenyang, Liaoning 110016, People's Republic of China *These authors contributed equally to this work Correspondence: Da Sun Institute of Life Sciences, Wenzhou University, Higher Educational Park, Wenzhou City 325035, Zhejiang Province, People's Republic of China Email sunday@wzu.edu.cn Maolan Zhang Chongqing University of Science and Technology, No. 19, Xijiao Branch Road, Jiulongpo District, Chongqing 400050, People's Republic of China Email zml@cqu.edu.cn Cancer immunotherapy is a promising approach that has recently gained its importance in treating cancer. Despite various approaches of immunotherapies being used to target cancer cells, they are either not effective against all types of cancer or for all patients. Although efforts are being made to improve the cancer immunotherapy in all possible ways, one important hindrance that lowers the immune response to kill cancer cells is the infiltration of Regulatory T (Treg) cells into the tumor cells, favoring tumor progression, on one hand, and inhibiting the activation of T cells to respond to cancer cells, on the other hand. Therefore, new anti-cancer drugs and vaccines fail to show promising results against cancer. This is due to the infiltration of Treg cells into the tumor region and suppression of anti-cancer activity. Thus, regardless of various types of immunotherapies being practiced, understanding the mechanisms of how Treg cells favor tumor progression and inhibition of anti-cancer activity is worthwhile. Therefore, the review highlights the importance of Tregs cells and how depletion of Treg cells can pave the way to an effective immunotherapy by activating the immune responses against cancer. Keywords: cancer immunotherapy, Treg cells, FoxP3, targeting Treg cells, anti-cancer

Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?

Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells

Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review

Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy

Targeting tumor-infiltrating tregs for improved antitumor responses

Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects

Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review

Antibody-based Cancer Immunotherapy by Targeting Regulatory T Cells

Regulatory T Cells and Their Clinical Applications in Antitumor Immunotherapy

The role of the programmed cell death protein-1/programmed death-ligand 1 pathway, regulatory T cells and T helper 17 cells in tumor immunity: a narrative review

Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells

Intratumoral regulatory T cells: markers, subsets and their impact on anti‐tumor immunity

Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies

Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting

Regulatory T cells in immune checkpoint blockade antitumor therapy

Immunotherapy of Cancer by Targeting Regulatory T cells

Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions

Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy

The functional regulation of Treg and its role in anti-tumor immunotherapy